Ulrich Pirron

1.1k total citations · 1 hit paper
8 papers, 785 citations indexed

About

Ulrich Pirron is a scholar working on Oncology, Surgery and Genetics. According to data from OpenAlex, Ulrich Pirron has authored 8 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Surgery and 4 papers in Genetics. Recurrent topics in Ulrich Pirron's work include Transplantation: Methods and Outcomes (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Polyomavirus and related diseases (3 papers). Ulrich Pirron is often cited by papers focused on Transplantation: Methods and Outcomes (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Polyomavirus and related diseases (3 papers). Ulrich Pirron collaborates with scholars based in United States, Switzerland and Australia. Ulrich Pirron's co-authors include Alessandro M. Vannucchi, Jingjin Li, Srđan Verstovšek, Jean‐Jacques Kiladjian, Shui He, Mark M. Jones, Ruben A. Mesa, William M. Garrett, Fabrizio Pane and Martin Grießhammer and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ulrich Pirron

8 papers receiving 771 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

2015 594 citations Alessandro M. Vannucchi, Jean‐Jacques Kiladjian et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Ulrich Pirron

Since Specialization

Citations

This map shows the geographic impact of Ulrich Pirron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Pirron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Pirron more than expected).

Fields of papers citing papers by Ulrich Pirron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Pirron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Pirron. The network helps show where Ulrich Pirron may publish in the future.

Co-authorship network of co-authors of Ulrich Pirron

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Pirron. A scholar is included among the top collaborators of Ulrich Pirron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Pirron. Ulrich Pirron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera breakdown → 2015 ·New England Journal of Medicine ·Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Ruben A. Mesa, Shui He, Mark M. Jones, William M. Garrett, Jingjin Li, Ulrich Pirron, Dany Habr, Srđan Verstovšek	594
2	Results of a prospective, randomized, open-label phase 3 study of ruxolitinib (RUX) in polycythemia vera (PV) patients resistant to or intolerant of hydroxyurea (HU): the RESPONSE trial 2014 ·Journal of Clinical Oncology ·Srđan Verstovšek, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, S. T. S. Durrant, Francesco Passamonti, Claire Harrison, Fabrizio Pane, Pierre Zachée, Ruben A. Mesa, Shui He, Mark M. Jones, William M. Garrett, Jingjin Li, Ulrich Pirron, Tomasz Lawniczek, Alessandro M. Vannucchi	14
3	Baseline Characteristics and Symptom Burden in RESPONSE: A Randomized, Open-Label, Phase 3 Study of Ruxolitinib In Polycythemia Vera Patients Resistant to or Intolerant of Hydroxyurea 2013 ·Blood ·Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer, Tamás Masszi, Simon Durrant, Pierre Zachée, Fabrizio Pane, Claire Harrison, Shui He, Lance Leopold, Jingjin Li, Ulrich Pirron, Tomasz Lawniczek, Srđan Verstovšek	7
4	RESPONSE: A randomized, open-label, phase III study of ruxolitinib in polycythemia vera (PV) patients resistant to or intolerant of hydroxyurea (HU). 2012 ·Journal of Clinical Oncology ·Srđan Verstovšek, Jean‐Jacques Kiladjian, Victor Sandor, (unknown), Jingjin Li, Shui He, William M. Garrett, (unknown), Ulrich Pirron, Bijoyesh Mookerjee, Alessandro M. Vannucchi	6
5	Everolimus in Pulmonary Transplantation: Pharmacokinetics and Exposure–Response Relationships 2006 ·The Journal of Heart and Lung Transplantation ·John M. Kovarik, Gregory I. Snell, Vincent G. Valentine, Robert M. Aris, Charles K. Chan, Heinz Schmidli, Ulrich Pirron	31
6	Everolimus Versus Azathioprine in Maintenance Lung Transplant Recipients: An International, Randomized, Double-Blind Clinical Trial 2005 ·American Journal of Transplantation ·G. Snell, Vincent G. Valentine, Patrizio Vitulo, Allan R. Glanville, David C. McGiffin, James E. Loyd, Antonio Román, R M Aris, Amparó Solé, Abdel Hmissi, Ulrich Pirron	121
7	Two-year results of an international, randomized, double-blind study of everolimus (RAD) vs azathioprine to inhibit the decline of pulmonary function in stable lung transplant recipients 2004 ·The Journal of Heart and Lung Transplantation ·G. Snell, Vincent G. Valentine, Robert B. Love, Patrizio Vitulo, Allan R. Glanville, Ulrich Pirron	5
8	One-year results of an international, randomized, double-blind study of everolimus vs azathioprine as adjunctive therapy to inhibit the decline of pulmonary function in stable lung or heart/lung transplant recipients 2003 ·The Journal of Heart and Lung Transplantation ·Greg Snell, Vincent G. Valentine, Robert B. Love, Patrizio Vitulo, Allan R. Glanville, Ulrich Pirron	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact